glycogen

glycogen
Name	Glycogen
Formula	(C6H10O5)n
Molar mass	Variable

glycogen Glycogen is a branched polysaccharide that functions as a primary short-term energy reserve in animals and some microorganisms. It consists of glucose units linked primarily by α-1,4-glycosidic bonds with α-1,6-branches, enabling rapid synthesis and mobilization during fluctuating metabolic demands. Studies from laboratories associated with Harvard University, Max Planck Society, National Institutes of Health, and institutions such as University of Cambridge and Massachusetts Institute of Technology have elucidated enzymology, structure, and pathological variants impacting human health.

Structure and Properties

Glycogen is organized as a multilamellar, highly branched polymer whose core architecture was characterized using techniques developed at Stanford University, University of Oxford, and ETH Zurich. The linear chains are connected by α-1,4 linkages while branch points occur via α-1,6 linkages approximately every 8–12 residues, a pattern defined through work at Rockefeller University and University of California, San Francisco. The globular particle (β-particle) can associate into larger α-particles, a topology investigated with methods from European Molecular Biology Laboratory and Lawrence Berkeley National Laboratory. Physical properties such as solubility, osmotic effect, and crystallinity were probed by researchers affiliated with Imperial College London and École Normale Supérieure.

Biosynthesis and Degradation

Biosynthesis begins with conversion of glucose to glucose-6-phosphate via hexokinase, an enzyme studied at Yale University and University of Toronto, then to glucose-1-phosphate by phosphoglucomutase, with activation to UDP-glucose by UDP-glucose pyrophosphorylase described in work from Karolinska Institutet. Glycogen synthase performs α-1,4 polymerization; branching enzyme (glycogen branch enzyme) introduces α-1,6 branches—both enzymes were traced genetically and biochemically in investigations at Johns Hopkins University and University of Pennsylvania. Degradation involves glycogen phosphorylase, debranching enzyme, and lysosomal acid alpha-glucosidase, pathways elaborated in collaborations including Cleveland Clinic and Mayo Clinic. Microbial analogs and comparative pathways have been characterized in studies at University of Tokyo and Waksman Institute.

Regulation and Hormonal Control

Hormonal regulation integrates signals from Glucagon, Epinephrine, and Insulin acting through signaling cascades characterized at Salk Institute, Cold Spring Harbor Laboratory, and University of California, San Diego. Insulin stimulates glycogen synthase via protein phosphatase 1 activation and phosphoinositide 3-kinase–Akt signaling, with mechanistic insights contributed by teams at Columbia University and University of Pennsylvania School of Medicine. Counter-regulatory hormones such as glucagon and epinephrine activate adenylate cyclase and protein kinase A, leading to glycogen phosphorylase activation—pathways examined in research from Princeton University and University of Michigan. AMP-activated protein kinase (AMPK) provides energy-sensing regulation; AMPK roles were defined in laboratories at University of Dundee and Mount Sinai School of Medicine.

Tissue Distribution and Physiological Roles

Major glycogen stores are found in liver and skeletal muscle, with liver glycogen maintaining systemic glucose homeostasis during fasting—a physiological role outlined by researchers at Beth Israel Deaconess Medical Center and University College London. Muscle glycogen supplies local ATP during contraction and exercise; this relationship was quantified in studies from Australian Institute of Sport and Karolinska Institutet. Brain, heart, and kidney contain smaller glycogen pools involved in localized metabolic support, with neuroglial glycogen metabolism investigated at University of Freiburg and University of California, Los Angeles. Invertebrate and unicellular glycogen analogs were compared in work at Cold Spring Harbor Laboratory and Max Planck Institute for Developmental Biology.

Clinical Significance and Glycogen Storage Diseases

Defects in glycogen metabolism cause glycogen storage diseases (GSDs), many classified by enzyme deficiency and genetic locus identified through consortia involving National Institute of Diabetes and Digestive and Kidney Diseases, European Medicines Agency, and clinical centers such as Great Ormond Street Hospital and Boston Children's Hospital. Examples include deficiencies of glycogen phosphorylase, debranching enzyme, branching enzyme, and acid maltase (acid alpha-glucosidase), with genotype–phenotype correlations reported by groups at Johns Hopkins Hospital and University of Milan. Therapeutic approaches—enzyme replacement therapy, gene therapy, substrate reduction, and diet management—have been trialed in multicenter studies coordinated through Food and Drug Administration and research at University of Pennsylvania Perelman School of Medicine and National Institutes of Health Clinical Center.

Measurement and Research Methods

Quantification and structural analysis of glycogen employ biochemical assays, chromatography, nuclear magnetic resonance, mass spectrometry, electron microscopy, and imaging modalities refined at institutions including University of Cambridge, Brookhaven National Laboratory, Karolinska Institutet, and McGill University. Clinical diagnostics use periodic acid–Schiff staining in pathology labs at Mayo Clinic and enzymatic assays standardized by World Health Organization collaborations. Advanced methods—stable isotope tracing, cryo-electron microscopy, and single-particle analysis—have been applied in studies from Max Planck Institute for Biophysical Chemistry, Lawrence Livermore National Laboratory, and Wellcome Trust Sanger Institute.

Category:Polysaccharides